الفهرس 
Evaluation of potential cardioprotective effects of an HMG-CoA reductase inhibitoragainst 5-fluorouracil-induced cardiotoxicity in rats
CONTENTSOnly 14 pages are availabe for public view
 |  | from | 208 |  |  |
| | | from | 208 | | |
Abstract
Background: 5-Fluorouracil (5-FU) is a highly effective anticancer drug, widely incorporated in the management of different solid tumours, and is a cornerstone therapy in colorectal cancer. Its use is associated with a wide range of different toxicities, including several reports of fatal cardiotoxicity which was first reported four decades ago. Since then, only some efforts were done to understand the pathophysiology and molecular mechanisms associated with this type of toxicity, moreover; there is no effective preventive measure against this toxic effect. Until now, myocardial ischemia due to coronary vasospasm is the most accepted theory. Aim: 5-FU cardiotoxicity is still controversial, the involvement of ROCK/Akt/eNOS and ET-1/ERK signalling in this toxic effect has not yet been reported. In addition, simvastatin was tested for its ability to ameliorate this toxicity through modulation of such molecular pathways. Methods: Adult Male Albino Wistar rats were used and allocated into four groups, where 5-FU (50 mg/kg/ week; i.p, 6 weeks) and simvastatin (15 mg/kg/day; p.o, 8 weeks) were either administered alone or combined except for the normal control group. Markers of cardiomyocyte injury and stress, inflammation, oxidative stress, apoptosis as well as histopathology were assessed. Additionally, the role of ROCK/Akt/eNOS and ET-1/ERK downstream from 5-FU activity to increase the vasoconstrictor response and endothelial dysfunction were tested. Finally, ECG monitoring was carried out to test for the perturbed myocardial electrical activity